TEE
CABA icon

Tibra Equities Europe’s Cabaletta Bio CABA Stock Holding History

Tibra Equities Europe’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-45,900
Closed -$395K – 66
2021
Q2 		$395K Buy
+45,900
New +$451K 0.12% 34

Other funds holding CABA

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Tibra Equities Europe's CABA Position: Q3 2021 in Review

Tibra Equities Europe sold out of Cabaletta Bio (CABA) in Q3 2021, closing a stake of 45,900 shares — an estimated $395K sold.

Tibra Equities Europe first reported a position in CABA in Q2 2021 and held it in 1 quarter. The position peaked at $395K in Q2 2021. 61 funds tracked by Wall St. Rank hold CABA as of Q3 2021.

  • Tibra Equities Europe reported no remaining Cabaletta Bio position as of Q3 2021 after selling out during the quarter.
  • Tibra Equities Europe sold 45,900 Cabaletta Bio shares in Q3 2021, an estimated $395K.
  • Tibra Equities Europe first reported a position in Cabaletta Bio in Q2 2021 and held it in 1 quarter.
  • Tibra Equities Europe's Cabaletta Bio position peaked at $395K in Q2 2021.
  • 61 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2021.

Based on Tibra Equities Europe's 13F filing for Q3 2021, filed 15 Nov 2021.